Release date:2019-12-31
In 2019, BDH Group passed the National Health Commission's Clinical Laboratory Center's inter-laboratory quality assessment for routine chemistry, lipids, special proteins, myocardial markers, glycosylated serum albumin, cystatin C, and serum amyloid protein A, as well as inter-laboratory quality assessment activities for lipid accuracy, enzyme accuracy, metabolites, and total protein accuracy verification. All assessments were qualified, and the company recently received the certification.